These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2870677)

  • 1. The status of vaccines to meningococcal and gonococcal disease.
    Gotschlich EC
    Ann Inst Pasteur Microbiol (1985); 1985; 136B(3):341-55. PubMed ID: 2870677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
    Noronha CP; Struchiner CJ; Halloran ME
    Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of a meningococcal vaccine.
    Poolman JT
    Infect Agents Dis; 1995 Mar; 4(1):13-28. PubMed ID: 7728353
    [No Abstract]   [Full Text] [Related]  

  • 5. New concepts in vaccines for mucosal non-enteric human bacterial pathogens.
    Westerink MA; Campagnari AA; Nelson MB; Murphy TF; Apicella MA
    Adv Exp Med Biol; 1989; 251():17-31. PubMed ID: 2481958
    [No Abstract]   [Full Text] [Related]  

  • 6. Neisseria proteomics for antigen discovery and vaccine development.
    Christodoulides M
    Expert Rev Proteomics; 2014 Oct; 11(5):573-91. PubMed ID: 25017717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal Detoxified Outer Membrane Vesicle Vaccines Enhance Gonococcal Clearance in a Murine Infection Model.
    Matthias KA; Connolly KL; Begum AA; Jerse AE; Macintyre AN; Sempowski GD; Bash MC
    J Infect Dis; 2022 Feb; 225(4):650-660. PubMed ID: 34498079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for prevention of meningococcal disease.
    Frasch CE
    Clin Microbiol Rev; 1989 Apr; 2 Suppl(Suppl):S134-8. PubMed ID: 2497956
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vaccines against Neisseria meningitidis].
    Ferrón L; Criado MT; Ferreirós CM
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):296-301. PubMed ID: 1391002
    [No Abstract]   [Full Text] [Related]  

  • 10. Neisseria meningitidis: vaccines and vaccine candidates.
    Al'Aldeen AA; Cartwright KA
    J Infect; 1996 Nov; 33(3):153-7. PubMed ID: 8945702
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccines against meningococcal meningitis: current status.
    Epidemiol Bull; 1994 Jul; 15(2):13-5. PubMed ID: 8086300
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of meningococcal group B OMV vaccines, beyond their brief.
    Petousis-Harris H
    Hum Vaccin Immunother; 2018 May; 14(5):1058-1063. PubMed ID: 29048985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease.
    Fredriksen JH; Rosenqvist E; Wedege E; Bryn K; Bjune G; Frøholm LO; Lindbak AK; Møgster B; Namork E; Rye U
    NIPH Ann; 1991 Dec; 14(2):67-79; discussion 79-80. PubMed ID: 1812438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysaccharides and membrane vaccines.
    Poolman JT
    Adv Biotechnol Processes; 1990; 13():57-86. PubMed ID: 1970737
    [No Abstract]   [Full Text] [Related]  

  • 15. Microbiology. A furtive pathogen revealed.
    Nassif X
    Science; 2000 Mar; 287(5459):1767-8. PubMed ID: 10755929
    [No Abstract]   [Full Text] [Related]  

  • 16. Meningococcal meningitis.
    Lancet; 1989 Mar; 1(8639):647-8. PubMed ID: 2564462
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tetravalent anti-meningococcal vaccine: serologic and clinical evaluation].
    Vescia N; Mastroeni I; Pompa MG; Signorelli C; Fara GM
    Ann Ig; 1989; 1(6):1293-8. PubMed ID: 2484465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Active immunization against serogroup B Neisseria meningitidis].
    Navarro-Alonso JA
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):513-9. PubMed ID: 14572386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2nd international workshop on Neisseria vaccines (Neisseria vaccines 2009).
    Romeu B; González E; Campa C; Holst J; Pérez O
    Expert Rev Vaccines; 2009 Aug; 8(8):987-92. PubMed ID: 19627182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a gonorrhoea vaccine: prospects, strategies and tactics.
    Gotschlich EC
    Bull World Health Organ; 1984; 62(5):671-80. PubMed ID: 6150769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.